149 related articles for article (PubMed ID: 19877883)
41. Preparation of [131I]lipiodol as a hepatoma therapeutic agent.
Lo JG; Wang AY; Wei YY; Lui WY; Chi CW; Chan WK
Int J Rad Appl Instrum A; 1992 Dec; 43(12):1431-5. PubMed ID: 1334953
[TBL] [Abstract][Full Text] [Related]
42. Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol).
Kobayashi H; Nakajo M; Yano T; Shimabukuro K; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1176-8. PubMed ID: 3005962
[No Abstract] [Full Text] [Related]
43. Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma.
Meléndez-Alafort L; Nadali A; Zangoni E; Banzato A; Rondina M; Rosato A; Mazzi U
Nucl Med Biol; 2009 Aug; 36(6):693-701. PubMed ID: 19647176
[TBL] [Abstract][Full Text] [Related]
44. Improved freeze-dried kit for the preparation of
Mallia MB; Chirayil V; Dash A
Appl Radiat Isot; 2018 Jul; 137():147-153. PubMed ID: 29625347
[TBL] [Abstract][Full Text] [Related]
45. I-131-Lipiodol therapy in liver neoplasms.
Risse JH; Grünwald F; Strunk H; Kleinschmidt R; Bender H; Biersack HJ
Hybridoma; 1999 Feb; 18(1):83-5. PubMed ID: 10211793
[TBL] [Abstract][Full Text] [Related]
46. Preparation and imaging of rhenium-188 labeled human serum albumin microsphere in orthotopic hepatoma rats.
Ni HC; Yu CY; Chen SJ; Chen LC; Lin CH; Lee WC; Chuang CH; Ho CL; Chang CH; Lee TW
Appl Radiat Isot; 2015 May; 99():117-21. PubMed ID: 25748057
[TBL] [Abstract][Full Text] [Related]
47. Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres.
Häfeli UO; Casillas S; Dietz DW; Pauer GJ; Rybicki LA; Conzone SD; Day DE
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):189-99. PubMed ID: 10219814
[TBL] [Abstract][Full Text] [Related]
48. 188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: a feasibility study in patients with advanced cirrhosis.
Lambert B; Bacher K; De Keukeleire K; Smeets P; Colle I; Jeong JM; Thierens H; Troisi R; De Vos F; Van de Wiele C
J Nucl Med; 2005 Aug; 46(8):1326-32. PubMed ID: 16085590
[TBL] [Abstract][Full Text] [Related]
49. Rhenium-188 based radiopharmaceuticals for treatment of liver tumours.
Lambert B; Bacher K; Defreyne L
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):305-10. PubMed ID: 19521309
[TBL] [Abstract][Full Text] [Related]
50. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
[No Abstract] [Full Text] [Related]
51. Intratumoral injection with [(188)Re]rhenium sulfide suspension for treatment of transplanted human liver carcinoma in nude mice.
Junfeng Y; Ruping Z; Xinlan D; Xiaofeng M; Jianying X; Weiqing H; Duanzhi Y; Wei Z; Hong X; Yongxian W; Knapp FF
Nucl Med Biol; 2000 May; 27(4):347-52. PubMed ID: 10938468
[TBL] [Abstract][Full Text] [Related]
52. Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma.
Uccelli L; Pasquali M; Boschi A; Giganti M; Duatti A
Nucl Med Biol; 2011 Feb; 38(2):207-13. PubMed ID: 21315276
[TBL] [Abstract][Full Text] [Related]
53. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma.
Garin E; Denizot B; Noiret N; Lepareur N; Roux J; Moreau M; Herry JY; Bourguet P; Benoit JP; Lejeune JJ
Nucl Med Commun; 2004 Oct; 25(10):1007-13. PubMed ID: 15381868
[TBL] [Abstract][Full Text] [Related]
54. Preparation and in vitro evaluation of B-lipiodol as a boron delivery agent for neutron capture therapy of hepatoma.
Chou FI; Lui WY; Wei YY; Chung RJ; Kai JJ; Chi CW
Anticancer Res; 1999; 19(3A):1759-64. PubMed ID: 10470112
[TBL] [Abstract][Full Text] [Related]
55. Effects of 90Y-microspheres on liver tumors: comparison of intratumoral injection method and intra-arterial injection method.
Lin WY; Tsai SC; Hsieh JF; Wang SJ
J Nucl Med; 2000 Nov; 41(11):1892-7. PubMed ID: 11079501
[TBL] [Abstract][Full Text] [Related]
56. Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study.
Bernal P; Raoul JL; Vidmar G; Sereegotov E; Sundram FX; Kumar A; Jeong JM; Pusuwan P; Divgi C; Zanzonico P; Stare J; Buscombe J; Minh CT; Saw MM; Chen S; Ogbac R; Padhy AK
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1448-55. PubMed ID: 17692473
[TBL] [Abstract][Full Text] [Related]
57. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs.
Garin E; Noiret N; Malbert C; Lepareur N; Roucoux A; Caulet-Maugendre S; Moisan A; Lecloirec J; Herry JY; Bourguet P
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):542-6. PubMed ID: 14691613
[TBL] [Abstract][Full Text] [Related]
58. Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohort.
Risse JH; Rabe C; Pauleit D; Reichmann K; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
Nuklearmedizin; 2006; 45(4):185-92. PubMed ID: 16964345
[TBL] [Abstract][Full Text] [Related]
59. (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
Lambert B; Bacher K; Defreyne L; Van Vlierberghe H; Jeong JM; Wang RF; van Meerbeeck J; Smeets P; Troisi R; Thierens H; De Vos F; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):344-52. PubMed ID: 16333675
[TBL] [Abstract][Full Text] [Related]
60. Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma.
Brans B; Van Laere K; Gemmel F; Defreyne L; Vanlangenhove P; Troisi R; Van Vlierberghe H; Colle I; De Hemptinne B; Dierckx RA
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):928-32. PubMed ID: 12111134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
